Renalytix plc
RNLXY- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001811115
No open-market purchases or sales by Renalytix plc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesRENXF
13F holders, Q2 2026
Institutional positions in Renalytix plc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 0
- 0 vs. Q1 2026
- Shares held
- 0
- 0 vs. Q1 2026
- Total value
- $0
- $0 vs. Q1 2026
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Holders and value by quarter
Institutions reporting RNLXY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $2.63K |
| Q2 2025 | 1 | $1.85K |
| Q1 2025 | 1 | $2.20K |
| Q4 2024 | 3 | $13.6K |
| Q3 2024 | 24 | $883.8K |
| Q2 2024 | 26 | $806.0K |
| Q1 2024 | 26 | $3.50M |
| Q4 2023 | 27 | $1.96M |
| Q3 2023 | 26 | $7.19M |
| Q2 2023 | 20 | $10.4M |
| Q1 2023 | 18 | $7.96M |
| Q4 2022 | 22 | $6.46M |
| Q3 2022 | 27 | $5.65M |
| Q2 2022 | 31 | $13.9M |
| Q1 2022 | 35 | $43.8M |
| Q4 2021 | 33 | $95.5M |
| Q3 2021 | 31 | $121.6M |
| Q2 2021 | 41 | $183.5M |
| Q1 2021 | 38 | $152.3M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Renalytix plc; share changes are against Q1 2026.
No institution reported holding RNLXY in Q2 2026.